UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 313

Sortiert nach

The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region

Annals of the rheumatic diseases, 2015-01, Vol.74 (1), p.311-314

2015

Volltextzugriff (PDF)

Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis

Annals of the rheumatic diseases, 2007-02, Vol.66 (2), p.253-256

2007

Volltextzugriff (PDF)

Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

Annals of the rheumatic diseases, 2007-07, Vol.66 (7), p.921-926

2007

Volltextzugriff (PDF)

The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept

Annals of the rheumatic diseases, 2011-02, Vol.70 (2), p.284-288

2011

Volltextzugriff (PDF)

Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients

Annals of the rheumatic diseases, 2012-01, Vol.71 (1), p.88-91

2012

Volltextzugriff (PDF)

Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis

Annals of the rheumatic diseases, 2009-04, Vol.68 (4), p.531-535

2009

Volltextzugriff (PDF)

Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study

Annals of the rheumatic diseases, 2010-05, Vol.69 (5), p.817-821

2010

Volltextzugriff (PDF)

Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation

Annals of the rheumatic diseases, 2009-11, Vol.68 (11), p.1787-1788

2009

Volltextzugriff (PDF)

Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis

Rheumatology (Oxford, England), 2003-10, Vol.42 (10), p.1189-1196

2003

Volltextzugriff (PDF)

Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus

Annals of the rheumatic diseases, 2003-01, Vol.62 (1), p.10-14

2003

Volltextzugriff (PDF)

Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2010-02, Vol.69 (2), p.409-412

2010

Volltextzugriff (PDF)

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2005-05, Vol.64 (5), p.704-707

2005

Volltextzugriff (PDF)

Effects of smoking on the ex vivo cytokine production in periodontitis

Journal of periodontal research, 2009-02, Vol.44 (1), p.28-34

2009

Volltextzugriff (PDF)

Clusterin: a protective mediator for ischemic cardiomyocytes?

American journal of physiology. Heart and circulatory physiology, 2005-11, Vol.289 (5), p.H2193-H2202

2005

Volltextzugriff (PDF)

Tissue factor pathway inhibitor is an inhibitor of factor VII‐activating protease

Journal of thrombosis and haemostasis, 2012-06, Vol.10 (6), p.1165-1171

2012

Volltextzugriff (PDF)

Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis

Annals of the rheumatic diseases, 2005-08, Vol.64 (8), p.1199-1204

2005

Volltextzugriff (PDF)

Chromatin-Independent Binding of Serum Amyloid P Component to Apoptotic Cells

The Journal of immunology (1950), 2001-07, Vol.167 (2), p.647-654

2001

Volltextzugriff (PDF)

FRI0092 New algorithm to approach ra patients receiving biologic therapies: Introducing immunogenicity assessment in the eular guidelines

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.340-340

2013

Volltextzugriff (PDF)

AB1297 Bridging ELISA as a secreening assay to monitor immunogenicity in routine clinical practice

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.711-711

2013

Volltextzugriff (PDF)

Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production

The Journal of experimental medicine, 1995-02, Vol.181 (2), p.775-779

1995

Volltextzugriff (PDF)

Response to: 'The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region’ by Rinaudo-Gaujous et al

Annals of the rheumatic diseases, 2015-08, Vol.74 (8), p.e41-e41

2015

Volltextzugriff (PDF)

An IL-13 promoter polymorphism associated with increased risk of allergic asthma

Genes and immunity, 1999-09, Vol.1 (1), p.61-65

1999

Volltextzugriff (PDF)

FRI0189 A preliminary algorithm introducing immunogenicity assessment in the management of ra patients receiving biotechnological therapies

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A436-A436

2013

Volltextzugriff (PDF)

FRI0188 The impact of immunogenicity on drug safety profile

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A436-A436

2013

Volltextzugriff (PDF)

SAT0187 Tocilizumab Standard Dose is an Overtreatment with Regard to Systemic IL-6 Receptor Blockade in Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.723-723

2015

Volltextzugriff (PDF)

1 – 25 von 313

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(263)

Publikationsform

Sprache

Englisch
(313)
Japanisch
(44)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(211)
Science & Technology
(205)
Life Sciences & Biomedicine
(203)
Biological And Medical Sciences
(126)
Immunology
(98)
Medical Sciences
(74)
Female
(62)
Animals
(60)
Male
(60)
Fundamental And Applied Biological Sciences. Psychology
(53)
Middle Aged
(49)
Rheumatology
(44)
Adult
(41)
Mice
(39)
Fundamental Immunology
(37)
Cells, Cultured
(36)
Aged
(33)
Antibodies, Monoclonal - Immunology
(33)
T-Lymphocytes - Immunology
(31)
Biochemistry & Molecular Biology
(30)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region

Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis

Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept

Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients

Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis

Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study

Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation

Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis

Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus

Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

Effects of smoking on the ex vivo cytokine production in periodontitis

Clusterin: a protective mediator for ischemic cardiomyocytes?

Tissue factor pathway inhibitor is an inhibitor of factor VII‐activating protease

Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis

Chromatin-Independent Binding of Serum Amyloid P Component to Apoptotic Cells

FRI0092 New algorithm to approach ra patients receiving biologic therapies: Introducing immunogenicity assessment in the eular guidelines

AB1297 Bridging ELISA as a secreening assay to monitor immunogenicity in routine clinical practice

Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production

Response to: 'The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region’ by Rinaudo-Gaujous et al

An IL-13 promoter polymorphism associated with increased risk of allergic asthma

FRI0189 A preliminary algorithm introducing immunogenicity assessment in the management of ra patients receiving biotechnological therapies

FRI0188 The impact of immunogenicity on drug safety profile

SAT0187 Tocilizumab Standard Dose is an Overtreatment with Regard to Systemic IL-6 Receptor Blockade in Rheumatoid Arthritis

Suchergebnisse filtern